MMP23B

Chr 1

matrix metallopeptidase 23B

Also known as: MIFR, MIFR-1, MMP22

The protein is a matrix metalloproteinase that degrades extracellular matrix components and may regulate potassium channel surface expression by retaining them in the endoplasmic reticulum. Based on the provided information, there are no established diseases associated with MMP23B mutations. The gene shows low constraint to loss-of-function variation (pLI = 0.12, LOEUF = 1.83), suggesting it may tolerate inactivating variants.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
140
P/LP submissions
0%
P/LP missense
1.83
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMMP23B
Population Constraint (gnomAD)
Low constraint (pLI 0.12) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
133 unique Pathogenic / Likely Pathogenic· 48 VUS of 185 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.83LOEUF
pLI 0.117
Z-score 0.38
OE 0.66 (0.211.83)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.54Z-score
OE missense 0.77 (0.591.03)
35 obs / 45.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.66 (0.211.83)
00.351.4
Missense OE0.77 (0.591.03)
00.61.4
Synonymous OE1.11
01.21.6
LoF obs/exp: 1 / 1.5Missense obs/exp: 35 / 45.2Syn Z: -0.38
DN
0.6841th %ile
GOF
0.7127th %ile
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

185 submitted variants in ClinVar

Classification Summary

Pathogenic125
Likely Pathogenic8
VUS48
Likely Benign4
125
Pathogenic
8
Likely Pathogenic
48
VUS
4
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
125
0
125
Likely Pathogenic
0
0
8
0
8
VUS
0
28
20
0
48
Likely Benign
0
2
1
1
4
Benign
0
0
0
0
0
Total0301541185

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MMP23B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →